• 1
    Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 18659.
  • 2
    Boshoff C. Kaposi's sarcoma associated herpesvirus. In: NewtonR, BeralV, WeissR, eds. Cancer surveys, vol. 33. Infections and human cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999.
  • 3
    Templeton AC. Kaposi's sarcoma. In: SommersSC, RosenPP, eds. Pathology annual. New York: Century-Crofts, 1981. 31536.
  • 4
    Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 1993; 54: 2636.
  • 5
    Gao S-J, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler JL, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Med, 1996; 2: 9258.
  • 6
    Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 11338.
  • 7
    Cook-Mozaffari P, Newton R, Beral V, Burkitt DP. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998; 78: 15218.
  • 8
    Bassett MT, Chokunonga E, Mauchaza B, Levy L, Ferlay J, Parkin DM. Cancer in the African population of Harare, Zimbabwe in 1990–92. Int J Cancer 1995; 63: 2936.
  • 9
    Sitas F, Blaauw D, Terblanche M, Madhoo J, Carrara H. Incidence of histologically diagnosed cancer in South Africa, 1992. National Cancer Registry of South Africa. Johannesburg; SAIMR, 1997.
  • 10
    Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 1238.
  • 11
    Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, et al. Risk factors for HHV-8 seropositivity and progression to Kaposi's sarcoma in a cohort of homosexual men, 1981–96. J Acquired Immune Deficiency Syndromes Human Retrovirol 1997: 14: A16 S1.
  • 12
    Grulich AE, Olsen SJ, Luo K, Hendry O, Cunningham P, Cooper DA, Gao SJ, Chang Y, Moore PS, Kaldor JM. Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection? J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 38793.
  • 13
    Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of Human Herpesvirus-8 infection. N Engl J Med 1998; 338: 948954.
  • 14
    Bourboulia D, Whitby D, Boshoff C, Carrara H, Newton R, Beral V, Lane A, Sitas F. Serological evidence for vertical transmission of KSHV/HHV-8 in healthy South African children. J Am Med Assoc 1998; 280: 312.
  • 15
    Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Patel M, Ruff P, Bezwoda WR, Hale M, Jentsh U, Retter E, et al. The seroepidemiology of HHV-8/KSHV in a large population of black cancer patients in South Africa. N Engl J Med 1999; 340: 186371.
  • 16
    Sitas F, Newton R, Boshoff C. Probability of mother-to-child transmission of HHV-8 increases with increasing maternal antibody titre for HHV-8. N Engl J Med, 1999; 340: 1923.
  • 17
    Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong F, Silvel B, Hart CA, Schulz TF. Prevalence and transmission of Kaposi's sarcoma associated herpesvirus (Human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77: 81720.
  • 18
    De Thé G, Bestetti G, Van Bevern M, Gessain A. Prevalence of human herpesvirus 8 before the acquired immunodeficiency disease syndrome-related empidmic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst 1999; 21: 18889.
  • 19
    Plancoulaine S, Abel L, Van Beveren M, Tregouet D-A, Joubert M, Tortevoye P, De Thé G, Gessain A. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 2000; 356: 10625.
  • 20
    Taylor JF, Smith PG, Bull D, Pike MC. Kaposi's sarcoma in Uganda: geography and ethnic distribution. Br J Cancer 1973; 26: 48395.
  • 21
    Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Wabinga H, Mbulaiteye S, Jaffe H, the Uganda Kaposi's Sarcoma Study Group, et al. A case-control study of risk factors for Kaposi's sarcoma among HIV-seronegative people in Uganda. Int J Cancer 2003; 103: 233240.
  • 22
    Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, et al. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterising its growth in Nod/SCID mice. Blood 1998; 91: 16719.
  • 23
    Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998; 90: 3957.
  • 24
    Davidovici B, Karakis I, Bourboulia D, Ariad S, Zong J-C, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, Boshoff C. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst, 2001; 93: 194202.
  • 25
    Dean AD, Dean JA, Burton JH, Dicker RC. Epi Info, version 5: a word processing, database and statistics program for epidemiology on micro-computers. Atlanta: Centers for Disease Control, 1990.
  • 26
    STATA. Stata software. College Park, TX: STATA, 2001.
  • 27
    Olsen SJ, Chang Y, Moore PS, Biggar RJ, Melbye M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 1998; 12: 19215.
  • 28
    Pauk J, Huang M-L, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343: 136977.
  • 29
    Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 1999; 91: 146874.
  • 30
    Campbell TB, Borok M, Gwanzura L. HHV-8 peripheral-blood viral load and the titer of antibodies against HHV-8. N Engl J Med 1999; 341: 12412.
  • 31
    Tedeschi R, Enbom M, Bidoli E, Linde A, De-Paoli P, Dillner J. Viral load of human herpesvirus-8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 2001; 39: 426973.
  • 32
    Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE, for the HIV Epidemiology Research Study Group. Blood-borne and sexual transmission of human herpesvirus 8 in women at risk for human immunodeficiency virus infection. N Engl J Med 2001; 344: 63743.